Rocket Pharmaceuticals Stock Price. Everything You Need To Know About The Rocket Pharmaceuticals Stock!
Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. The company is headquartered in New York City, New York and currently employs 240 full-time employees. The company went IPO on 2015-02-18. The firm’s clinical programs using lentiviral vector (LVV)-based gene therapy are for the treatment of Fanconi Anemia (FA), a genetic disease that leads to bone marrow failure and potentially cancer, Leukocyte Adhesion Deficiency-I (LAD-I), a severe paediatric genetic disorder that causes recurrent and life-threatening infections which are frequently fatal, and Pyruvate Kinase Deficiency (PKD), a rare, monogenic red blood cell disorder resulting in increased red cell destruction and mild to life-threatening anemia. The firm’s first clinical program using adeno-associated virus (AAV)-based gene therapy is for Danon Disease, a pediatric heart failure condition. The company also has a preclinical AAV-based gene therapy program in PKP2-arrhythmogenic cardiomyopathy (ACM) and BAG3-associated dilated cardiomyopathy (DCM).
Rocket Pharmaceuticals Stock Price. Everything You Need To Know About The Rocket Pharmaceuticals Stock! performance
- Employees 240
- Company HQ New York City
- Website https://www.rocketpharma.com/
- RCKT Asset Type Common Stock
- RCKT Market Capitalization 2B
- Earnings Per Share -2.92
- Dividends Per Share None
- Dividend Date 2018-01-05
- Quarterly Earnings Growth 0
Rocket Pharmaceuticals is an innovative biotechnology company that focuses on developing transformative gene therapies for rare genetic disorders. With its cutting-edge technology, Rocket aims to address the unmet needs of patients suffering from devastating genetic diseases. For retail investors from Malaysia, Thailand, Indonesia, and Vietnam interested in investing in Rocket Pharmaceuticals, there are a few steps to consider. Firstly, open an account with Zorion, a trusted investment platform that provides access to real US stocks and Pre-IPO companies. Next, conduct thorough research on Rocket Pharmaceuticals, including studying their financials, drug pipeline, and competitive landscape. Finally, consult Zorion’s investment insights and recommendations to make informed decisions and continuously explore educational resources to enhance your knowledge in the field of gene therapies. Start investing in Rocket Pharmaceuticals with Zorion today and be part of the future of medicine.
